Premacure/Shire transaction . . .
Fine tuning INSM corporate strategy for liposome development . . .
Anyone else notice that the housecleaning continued? Yahoo only lists 41 employees. That is because of the CRO for manufacturing, but they are still maintaining R&D labs onsite based upon hiring and intership for liposome development. That is the only way they can generate new IP.
I looked for an SEC filing for something this AM, but I was too early. It was not up when I got back at 7 AM from delivering the wife to the train. So let's see what the clinical updates are and whether WL extends the discussion about the liposome. Remember, if they have a liposome master file, they can collaborate with other companies to augment that file. They just need one pulmonary vaccine giant, or some pulmonary drug that would really achieve improved safety or efficacy. I have the reminder for the 3 PM presentation.